AR074309A1 - Compuestos anti-inflamatorios y sus composiciones farmaceuticas, dentifricas y adhesivas. metodo - Google Patents
Compuestos anti-inflamatorios y sus composiciones farmaceuticas, dentifricas y adhesivas. metodoInfo
- Publication number
- AR074309A1 AR074309A1 ARP090104324A ARP090104324A AR074309A1 AR 074309 A1 AR074309 A1 AR 074309A1 AR P090104324 A ARP090104324 A AR P090104324A AR P090104324 A ARP090104324 A AR P090104324A AR 074309 A1 AR074309 A1 AR 074309A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical
- dentifrical
- adhesive compositions
- inflammatory compounds
- mammal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Dental Preparations (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Reivindicación 1: Un método para tratar y/o prevenir la inflamación en un mamífero, especialmente un ser humano, que lo necesita, donde dicho método comprende administrar una cantidad eficaz de un compuesto de fámula (1) o una sal farmacéuticamente aceptable del mismo en la que n es un número entero de cero a tres. Reivindicación 14: Un método para tratar y/o prevenir la inflamación en un mamífero, especialmente un ser humano, que lo necesita, que comprende administrar una composición farmacéutica que comprende una cantidad eficaz de un compuesto de fórmula (1), o una sal farmacéuticamente aceptable del mismo en la que n es un número entero de cero a tres, al menos un agente anti-inflamatorio adicional, al menos un agente antioxidante, un agente antimicrobiano y un excipiente farmacéuticamente aceptable.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11290008P | 2008-11-10 | 2008-11-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR074309A1 true AR074309A1 (es) | 2011-01-05 |
Family
ID=42153302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090104324A AR074309A1 (es) | 2008-11-10 | 2009-11-09 | Compuestos anti-inflamatorios y sus composiciones farmaceuticas, dentifricas y adhesivas. metodo |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20110207817A1 (es) |
| EP (1) | EP2361087A4 (es) |
| JP (1) | JP2012508256A (es) |
| CN (1) | CN102271675A (es) |
| AR (1) | AR074309A1 (es) |
| TW (1) | TW201029651A (es) |
| WO (1) | WO2010054344A1 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11185526B2 (en) * | 2018-09-04 | 2021-11-30 | Babak Ghalili | Cannabinoid, menthol and caffeine dissolvable film compositions, devices and methods |
| US11229610B2 (en) | 2018-09-04 | 2022-01-25 | Babak Ghalili | Cannabinoid and menthol gel compositions, patches and methods |
| US10813889B2 (en) * | 2018-09-04 | 2020-10-27 | Babak Ghalili | Cannabinoid and menthol compositions and methods |
| US11344495B2 (en) | 2018-09-04 | 2022-05-31 | Babak Ghalili | Veterinary cannabinoid, menthol and anesthetic compositions and methods |
| US10813963B2 (en) | 2018-09-04 | 2020-10-27 | Babak Ghalili | Veterinary cannabinoid and menthol compositions and methods |
| US11147775B2 (en) * | 2018-09-04 | 2021-10-19 | Babak Ghalili | Cannabinoid and menthol gel compositions, patches and methods |
| US11376227B2 (en) | 2018-09-04 | 2022-07-05 | Babak Ghalili | Cannabinoid and menthol gum and lozenge compositions and methods |
| US11235013B2 (en) * | 2018-09-04 | 2022-02-01 | Babak Ghalili | Cannabinoid, menthol and caffeine dissolvable film compositions, devices and methods |
| CN113376386A (zh) * | 2020-03-09 | 2021-09-10 | 中国科学院广州生物医药与健康研究院 | 一种病毒性肺炎的标志物及其应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1156689A1 (ru) * | 1982-09-27 | 1985-05-23 | Харьковский Научно-Исследовательский Химико-Фармацевтический Институт | Противовоспалительное средство "гипозоль |
| US4672076A (en) * | 1984-04-27 | 1987-06-09 | Warner-Lambert Company | Non-steroidal anti-inflammatory compounds and compositions thereof |
| US6375963B1 (en) * | 1999-06-16 | 2002-04-23 | Michael A. Repka | Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof |
| FR2797763B1 (fr) * | 1999-08-25 | 2002-06-21 | Gilles Brun | Dentifrice liquide sans rincage et sans abrasif, et dispositif de pulverisation |
| BR0114540A (pt) * | 2000-10-10 | 2004-01-13 | Block Drug Co | Revestimento adesivo para dentadura em pelìcula extrudada |
| JP3824078B2 (ja) * | 2001-06-27 | 2006-09-20 | ライオン株式会社 | 練歯磨剤組成物 |
| US20060127505A1 (en) * | 2002-01-16 | 2006-06-15 | David Haines | Anti-inflammatory formulations |
| US20060134025A1 (en) * | 2004-12-17 | 2006-06-22 | Colgate-Palmolive Company | Oral compositions containing extracts of Rosmarinus and related methods |
| JP2007161681A (ja) * | 2005-12-16 | 2007-06-28 | Mitsui Chemicals Inc | しわ防止および皮膚状態改善剤 |
| US20080131420A1 (en) * | 2006-07-13 | 2008-06-05 | Accentia, Inc. | Methods and compositions for treating mucosal inflammation |
| JP5069030B2 (ja) * | 2007-03-30 | 2012-11-07 | 小林製薬株式会社 | 義歯安定剤 |
-
2009
- 2009-11-09 TW TW098137978A patent/TW201029651A/zh unknown
- 2009-11-09 AR ARP090104324A patent/AR074309A1/es not_active Application Discontinuation
- 2009-11-10 US US13/127,739 patent/US20110207817A1/en not_active Abandoned
- 2009-11-10 EP EP09825574A patent/EP2361087A4/en not_active Withdrawn
- 2009-11-10 WO PCT/US2009/063773 patent/WO2010054344A1/en active Application Filing
- 2009-11-10 JP JP2011535734A patent/JP2012508256A/ja active Pending
- 2009-11-10 CN CN2009801542103A patent/CN102271675A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP2361087A1 (en) | 2011-08-31 |
| CN102271675A (zh) | 2011-12-07 |
| US20110207817A1 (en) | 2011-08-25 |
| TW201029651A (en) | 2010-08-16 |
| JP2012508256A (ja) | 2012-04-05 |
| WO2010054344A1 (en) | 2010-05-14 |
| EP2361087A4 (en) | 2012-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR074309A1 (es) | Compuestos anti-inflamatorios y sus composiciones farmaceuticas, dentifricas y adhesivas. metodo | |
| ECSP099780A (es) | Nuevos inhibidores macrociclicos de la replicacion del virus de hepatitis c | |
| GT200600096A (es) | Composicion farmaceutica para el tratamiento del cancer | |
| CL2018000318A1 (es) | Compuestos derivados de piridinona, inhibidores de bromodominio; composición farmacéutica que los comprende; y su uso en el tratamiento de enfermedades del cáncer. (solicitud divisional 201600925) | |
| AR067495A1 (es) | Composiciones farmaceuticas y procedimientode tratamientos de trastornos de ojo seco | |
| CL2011000504A1 (es) | Compuestos derivados de piridin-4-il-tiazol-2il-amida 2-amida-pirrolidin-1,2-dicarboxilico, inhibidores de quinasa de fosfatidil-inositol-3; composicion farmaceutica que comprende a uno de los compuestos; y uso de los compuestos en la preparacion de un medicamento para el tratamiento del cancer. | |
| BRPI0809164B8 (pt) | Composição para administração tópica e composição farmacêutica compreendendo a referida composição | |
| BR112015022096A8 (pt) | compostos moduladores de canal de sódio, composição que os compreende e uso dos mesmos | |
| BR112012023021A2 (pt) | compostos de indazol e seus usos | |
| BRPI0717773A2 (pt) | Composto, composição farmacêutica, e, métodos para tratar ou prevenir câncer, uma condição inflamatória, uma condição imunológica ou uma condição metabólica, e para inibir uma quinase em uma célula que expressa a dita quinase | |
| CL2009000780A1 (es) | Compuestos derivados de heterociclil-pirano-heterociclilo, heterociclil-oxepina-heterociclilo, benzopirano-heterociclilo y benzoxepina-heterociclilo sustituidos; composicion farmaceutica; procedimiento de preparacion de la composicion; kit farmaceutico; y su uso en el tratamiento del cancer, mediado por la inhibicion de pi3k. | |
| ECSP099792A (es) | Nuevos peptidos inhibidores de la replicacion del virus de hepatitis c | |
| BR112012021086A2 (pt) | composições farmacêuticas de composto espiro-oxindole para administração tópica e seu uso como agentes terapêuticos | |
| BR112012009376A2 (pt) | composição farmacêutica, forma de dosagem farmacêutica, processo para a sua preparação, métodos de tratamento e seu uso | |
| AR070299A1 (es) | Derivados de pirazolopirimidinas como inhibidores de quinasas dependientes de ciclinas, usos y composiciones farmaceuticas | |
| UY30819A1 (es) | Derivados de pirazol, composiciones farmacéuticas conteniéndolos, procesos de preparacion y aplicaciones | |
| AR059575A1 (es) | Metodo para el tratamiento de enfermedades inflamatorias | |
| BRPI0709581A8 (pt) | compostos de bicicloeteroarila como moduladores de px27 e seu uso | |
| EA201071040A1 (ru) | Новые производные 1-бензил-3-гидроксиметилиндазола и их применение при лечении заболеваний, обусловленных экспрессией mcp-1, cx3cr1 и p40 | |
| BR112012033077B8 (pt) | Composição farmacêutica para administração intravenosa, uso de uma composição farmacêutica, e, kit | |
| AR048336A1 (es) | Hidrocloruro de (4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il)-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos | |
| CL2011001131A1 (es) | Uso de una formulacion que sirve para preparar un medicamento para una inyeccion, que reduce al minimo la inflamacion en el sitio de la inyeccion de un anticuerpo, y donde la formulacion comprendeun anticuerpo 2h7 y variantes del anticuerpo y polivinilpirrolidona (pvp) | |
| AR080242A1 (es) | Composiciones veterinarias. usos. | |
| MX2013000694A (es) | Vitamina c y vitamina k libre de cromo, y composiciones de estas para tratar un estado o enfermedad en las que interviene nfkb. | |
| UY38614A (es) | Derivados de benzodiazepinas como inhibidores del rsv |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |